Clopidogrel - Hepatitis and liver failure;Clopidogrel - Hepatitis und leberversagen

Internistische Praxis

Volumn 48, Issue 3, 2008, Pages 606-607

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BISOPROLOL; CLOPIDOGREL; ENALAPRIL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; HEART INFARCTION; HEPATITIS; HUMAN; LIVER FAILURE; LIVER TOXICITY; PROPHYLAXIS; SHORT SURVEY; THROMBOCYTE AGGREGATION; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 50149096163     PISSN: 00209570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Schwabe U, Paffrath D, Hrsg. Arzneiverordnungs-Report 2007. Heidelberg: Springer; 2008. S. 432-435.
2. Hollmuller I, et al. Clinico-histopathological characteristics of clopidogrel-induced hepatic injury: case report and review of literature. Eur J Gastroenterol Hepatol 2006; 18: 931-934.
3. Ng JA, Goldberg N, Tafreshi MJ. Clopidogrel-induced hepatotoxicity and fever. Pharmacotherapy 2006; 26: 1023-1026.
4. Beltran-Robles M, et al. Hepatotoxicity induced by clopidogrel. J Hepatol 2004; 40: 560-562.
5. Sanovi-Aventis Deutschland GmbH. Fachinformation »Plavix 75 mg Filmtabletten«. Stand: Juni 2007.
6. Bristol-Myers Squibb GmbH. Fachinformation zu »Iscover 75 mg Filmtabletten«. Stand: Juni 2007.
7. Internet (http://www.akdae.de/20/20/Archiv/2008/20080404.html).